Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FIDAXOMICIN vs FINGOLIMOD: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FIDAXOMICIN vs FINGOLIMOD: Safety Overview

Metric FIDAXOMICIN FINGOLIMOD
Total FAERS Reports 1,491 70,944
Deaths Reported 181 1,007
Death Rate 12.1% 1.4%
Hospitalizations 410 9,066
Average Patient Age 63.7 yrs 43.7 yrs
% Female Patients 61.8% 78.3%
FDA Approval Date Feb 2, 2026 Dec 18, 2020
Manufacturer Merck Sharp & Dohme LLC AvKARE
Route ORAL ORAL
Marketing Status Prescription Prescription